EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019–2023

Obadiah Kenji iD, Fernando Motta, Thomas Williams, Nicole Wolter, Ian G Barr, Clyde Dapat, Maria Zambon, Lucy Mosscrop, Mei Shang, Sergejs Nikisins, Siddhivinayak Hirve iD, Wenqing Zhang und 1 weitere

Influenza and Other Respiratory Viruses · 2026

DOI: 10.1111/irv.70195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2026. Verfasst von Obadiah Kenji und 12 weiteren Autor:innen. Beteiligte Einrichtung: World Health Organization, Global Influenza Programme, Geneva, Switzerland. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human, Genome, Viral, Epidemiological Monitoring. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

From 2016 to 2018, the World Health Organization (WHO) initiated a global RSV surveillance pilot program in 14 countries, expanding to 25 countries from 2019 to 2023. As part of this, a sequencing program was introduced to improve the understanding of RSV global genetic diversity prior to and following the introduction of interventions such as passive immunization, vaccines, and antivirals. Methodology All RSV sequence data submitted to GISAID by WHO project countries from January 1, 2019, to December 31, 2023, was analyzed to evaluate progress in sequencing, lineage distribution, and RSV fusion (F) protein diversity.

Results

From 2019 to 2023, 44,571 RSV sequences were submitted to GISAID, including 61% RSV‐A and 39% RSV‐B, with 34% being whole‐genome sequences. WHO project countries contributed 13,280 sequences (30%), with submissions increasing from 158 in 2020 to 3716 in 2023. Median data submission time improved from 1116 days in 2020 to 206 days in 2023. The dominant lineage detected was A.D .1 (20%) for RSV‐A and B.D.4.1.1 (29%) for RSV‐B. The F protein sequences showed high amino acid conservation: 97% for RSV‐A and 96% for RSV‐B.

Conclusion

Substantial progress has been made in RSV genomic sequencing capacities in WHO project countries as seen by the increased submissions and improved timeliness of sequence data. RSV exhibited co‐circulating lineages (RSV‐A and RSV‐B) with low F protein diversity. It is important to sustain and further strengthen RSV sequencing capacities in all WHO regions as part of the ongoing WHO Global Genomic Surveillance strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanGenome, ViralEpidemiological MonitoringHumansWorld Health OrganizationGlobal HealthGenetic VariationPhylogenyGenomicsViral Fusion Proteins

Stichwörter der Autor:innen

RSVRSV project countriescapacity buildinggenomic sequencing

Substanzen

Viral Fusion Proteins

Autor:innen und Institutionen

  • World Health Organization, Global Influenza Programme, Geneva, Switzerland.
  • Laboratório de Vírus Respiratórios Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.
  • Child Life and Health, University of Edinburgh, Edinburgh, UK.
  • Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, Peter Doherty Institute, Melbourne, Australia.

ORCID-Profile: Obadiah Kenji, Siddhivinayak Hirve

Förderung

  • Bill and Melinda Gates Foundation

Zitieren

APA

Kenji, O., Motta, F., Williams, T., Wolter, N., Barr, I. G., Dapat, C., Zambon, M., Mosscrop, L., Shang, M., Nikisins, S., Hirve, S., Zhang, W., & WHO RSV Surveillance Group (2026). The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019–2023. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70195

Vancouver

Kenji O, Motta F, Williams T, Wolter N, Barr IG, Dapat C, et al. The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019–2023. Influenza and Other Respiratory Viruses. 2026. doi:10.1111/irv.70195

BibTeX
@article{Kenji2026,
  author = {Kenji, Obadiah and Motta, Fernando and Williams, Thomas and Wolter, Nicole and Barr, Ian G and Dapat, Clyde and Zambon, Maria and Mosscrop, Lucy and Shang, Mei and Nikisins, Sergejs and Hirve, Siddhivinayak and Zhang, Wenqing and WHO RSV Surveillance Group, WHO RSV Surveillance Group},
  title = {The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019–2023},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2026},
  doi = {10.1111/irv.70195}
}
Kostenlos starten →